<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Decreased uncoupling protein (UCP)3 is associated with <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> in muscle of <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">pre-diabetic</z:e> and diabetic individuals, but the function of UCP3 remains unclear </plain></SENT>
<SENT sid="1" pm="."><plain>Our goal was to elucidate mechanisms underlying the negative correlation between UCP3 and <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> in muscle </plain></SENT>
<SENT sid="2" pm="."><plain>We determined effects of physiologic UCP3 overexpression on <z:chebi fb="105" ids="17234">glucose</z:chebi> and fatty acid oxidation and on <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> uncoupling and reactive oxygen species (ROS) production in L6 muscle cells </plain></SENT>
<SENT sid="3" pm="."><plain>An adenoviral construct caused a 2.2- to 2.5-fold increase in UCP3 protein </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="2" ids="29889">Palmitate</z:chebi> oxidation was increased in muscle cells incubated under normoglycemic or <z:e sem="disease" ids="C0851834" disease_type="Disease or Syndrome" abbrv="">hyperglycemic conditions</z:e>, whereas adenoviral green fluorescent protein <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> or <z:hpo ids='HP_0011010'>chronic</z:hpo> low doses of the uncoupler <z:chebi fb="0" ids="39352">dinitrophenol</z:chebi> had no effect </plain></SENT>
<SENT sid="5" pm="."><plain>Increased UCP3 did not affect <z:chebi fb="105" ids="17234">glucose</z:chebi> oxidation, whereas <z:chebi fb="0" ids="39352">dinitrophenol</z:chebi> and insulin treatments caused increases </plain></SENT>
<SENT sid="6" pm="."><plain>Basal oxygen consumption, assessed in situ using self-referencing microelectrodes, was not significantly affected, whereas <z:chebi fb="0" ids="39352">dinitrophenol</z:chebi> caused increases </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0001427'>Mitochondrial</z:hpo> membrane potential was decreased by <z:chebi fb="0" ids="39352">dinitrophenol</z:chebi> but was not affected by increased UCP3 expression </plain></SENT>
<SENT sid="8" pm="."><plain>Finally, <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> ROS production decreased significantly with increased UCP3 expression </plain></SENT>
<SENT sid="9" pm="."><plain>Results are consistent with UCP3 functioning to facilitate fatty acid oxidation and minimize ROS production </plain></SENT>
<SENT sid="10" pm="."><plain>As impaired fatty acid metabolism and ROS handling are important precursors in muscular <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, UCP3 is an important therapeutic target in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>